Home > Insider Trading > Filing (0001127602-11-033121)

Filing Details

Accession Number:: 0001127602-11-033121
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-12-22 19:04:50
Reporting Period:: 2011-12-20

Filing Date:: 2011-12-22
Accepted Time:: 2011-12-22 19:04:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
850693	Allergan Inc	AGN	Pharmaceutical Preparations (2834)	951622442

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1051578	I E David Pyott	2525 Dupont Drive Irvine CA 92612	Chairman, President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-12-20	250,000	$32.39	456,923	No	4	M	Indirect	By Living Trust
Common Stock	Disposition	2011-12-20	250,000	$85.91	206,923	No	4	S	Indirect	By Living Trust
Common Stock	Acquisiton	2011-12-21	250,000	$32.39	456,923	No	4	M	Indirect	By Living Trust
Common Stock	Disposition	2011-12-21	250,000	$86.05	206,923	No	4	S	Indirect	By Living Trust
Common Stock	Acquisiton	2011-12-22	66,754	$32.39	273,677	No	4	M	Indirect	By Living Trust
Common Stock	Disposition	2011-12-22	66,754	$86.35	206,923	No	4	S	Indirect	By Living Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Indirect	By Living Trust
No	4	S	Indirect	By Living Trust
No	4	M	Indirect	By Living Trust
No	4	S	Indirect	By Living Trust
No	4	M	Indirect	By Living Trust
No	4	S	Indirect	By Living Trust

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2011-12-20	250,000	$0.00	250,000	$32.39
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2011-12-21	250,000	$0.00	250,000	$32.39
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2011-12-22	66,754	$0.00	66,754	$32.39

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
316,754	2012-04-24	No	4	M	Indirect
66,754	2012-04-24	No	4	M	Indirect
0	2012-04-24	No	4	M	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	31,252	Direct
Common Stock	2,168	Indirect	By 401(k) Trust
Common Stock	2,880	Indirect	By Esop Trust

Footnotes

The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 3, 2011.
The price reported in this Form 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $85.90 to $85.96, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holders of Allergan, Inc., or the staff of the Securities Exchange Commission, the full information regarding the number of shares sold at each price range sert forth in this footnote.
The price reported in comlumn 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $85.90 to $86.72, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities Exchange Commission, upon request, the full information regarding the number of shares sold at each price within the range set forth in this footnote.
The price reported in column 4 is the weighted average price. These shares were sold in multiple transaction at prices ranging from $85.90 to $87.11, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities Exchange Commission, upon request, the full information regarding the number of shares sold at each price within the range set forth in this footnote.
David and Julianna Pyott Living Trust dated June 14, 1999, in which the reporting person has a pecuniary interest and of which the reporting person and his spouse are each trustees.
Shares allocated to reporting person's SIP account as of reporting date.
Shares allocated to the reporting person's ESOP account as of reporting date.
The option became exercisable in four equal annual installments beginning 4/24/2003.